Durvalumab in locally advanced unresectable non-small cell lung cancer – Benchmarking real-world outcomes in England against published trial data
Outcomes are comparable to the PACIFIC trial suggesting the trial data are generalisable to the real-world setting. This study demonstrates how population-based data can provide continued evaluation of clinical outcomes in routine care.
Authors
- Emma Kipps (ORCID: https://orcid.org/0000-0002-4912-8502)
- Katherine E Henson (ORCID: https://orcid.org/0000-0002-5865-1370)
- Nadza Tokaca (ORCID: https://orcid.org/0000-0001-7825-4404)
- Sarah Lawton (ORCID: https://orcid.org/0000-0002-8909-2057)
- L Webster
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- NHS Digital (GB)
Publication Details
- Journal
- Lung Cancer
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1016/j.lungcan.2025.108752
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00